{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:56:14Z","timestamp":1790819774260,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"ERA-NET Cofund JPIAMR Action","award":["MURYXIN"],"award-info":[{"award-number":["MURYXIN"]}]},{"name":"European Union's Horizon 2020 Framework Programme","award":["857287"],"award-info":[{"award-number":["857287"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"DOI":"10.1007\/s00204-026-04566-x","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:52:26Z","timestamp":1790758346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Polymyxin antibiotics induce nephrotoxicity through the selective inhibition of Complex I-dependent respiration in mouse and rat mitochondria"],"prefix":"10.1007","author":[{"given":"Edgars","family":"Liepinsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerija","family":"Meinardte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristaps","family":"Krims-Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislava","family":"Korzh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduards","family":"Sevostjanovs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Cirule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maija","family":"Dambrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Rabanal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"4566_CR1","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1128\/AAC.00280-12","volume":"56","author":"K Abdelraouf","year":"2012","unstructured":"Abdelraouf K, Braggs KH, Yin T et al (2012) Characterization of polymyxin B-induced nephrotoxicity: implications for dosing regimen design. Antimicrob Agents Chemother 56:4625\u20134629. https:\/\/doi.org\/10.1128\/AAC.00280-12","journal-title":"Antimicrob Agents Chemother"},{"key":"4566_CR2","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1006\/exnr.1999.7052","volume":"157","author":"JT Chun","year":"1999","unstructured":"Chun JT, Wang L, Pasinetti GM et al (1999) Glycoprotein 330\/megalin (LRP-2) has low prevalence as mRNA and protein in brain microvessels and choroid plexus. Exp Neurol 157:194\u2013201. https:\/\/doi.org\/10.1006\/exnr.1999.7052","journal-title":"Exp Neurol"},{"key":"4566_CR3","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.etp.2013.01.008","volume":"65","author":"C Dai","year":"2013","unstructured":"Dai C, Li J, Li J (2013) New insight in colistin induced neurotoxicity with the mitochondrial dysfunction in mice central nervous tissues. Exp Toxicol Pathol 65:941\u2013948. https:\/\/doi.org\/10.1016\/j.etp.2013.01.008","journal-title":"Exp Toxicol Pathol"},{"key":"4566_CR4","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1128\/AAC.00070-14","volume":"58","author":"C Dai","year":"2014","unstructured":"Dai C, Li J, Tang S et al (2014) Colistin-induced nephrotoxicity in mice involves the mitochondrial, death receptor, and endoplasmic reticulum pathways. Antimicrob Agents Chemother 58:4075\u20134085. https:\/\/doi.org\/10.1128\/AAC.00070-14","journal-title":"Antimicrob Agents Chemother"},{"key":"4566_CR5","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1007\/s11033-019-04646-5","volume":"46","author":"C Dai","year":"2019","unstructured":"Dai C, Tang S, Biao X et al (2019) Colistin induced peripheral neurotoxicity involves mitochondrial dysfunction and oxidative stress in mice. Mol Biol Rep 46:1963\u20131972. https:\/\/doi.org\/10.1007\/s11033-019-04646-5","journal-title":"Mol Biol Rep"},{"key":"4566_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/s0005-2728(98)00029-2","volume":"1364","author":"M Degli Esposti","year":"1998","unstructured":"Degli Esposti M (1998) Inhibitors of NADH-ubiquinone reductase: an overview. Biochim Biophys Acta 1364:222\u2013235. https:\/\/doi.org\/10.1016\/s0005-2728(98)00029-2","journal-title":"Biochim Biophys Acta"},{"key":"4566_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/ja.2013.111","volume":"67","author":"ZZ Deris","year":"2014","unstructured":"Deris ZZ, Akter J, Sivanesan S et al (2014) A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity. J Antibiot (Tokyo) 67:147\u2013151. https:\/\/doi.org\/10.1038\/ja.2013.111","journal-title":"J Antibiot (Tokyo)"},{"key":"4566_CR8","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nature11541","volume":"491","author":"Y Feng","year":"2012","unstructured":"Feng Y, Li W, Li J et al (2012) Structural insight into the type-II mitochondrial NADH dehydrogenases. Nature 491:478\u2013482. https:\/\/doi.org\/10.1038\/nature11541","journal-title":"Nature"},{"key":"4566_CR9","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3390\/molecules24030653","volume":"24","author":"Z Gai","year":"2019","unstructured":"Gai Z, Samodelov SL, Kullak-Ublick GA, Visentin M (2019) Molecular mechanisms of colistin-induced nephrotoxicity. Molecules 24:653. https:\/\/doi.org\/10.3390\/molecules24030653","journal-title":"Molecules"},{"key":"4566_CR10","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1097\/SHK.0000000000001315","volume":"52","author":"M Makrecka-Kuka","year":"2019","unstructured":"Makrecka-Kuka M, Korzh S, Vilks K et al (2019) Mitochondrial function in the kidney and heart, but not the brain, is mainly altered in an experimental model of endotoxaemia. Shock 52:e153. https:\/\/doi.org\/10.1097\/SHK.0000000000001315","journal-title":"Shock"},{"key":"4566_CR11","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02391-16","volume":"61","author":"P Manchandani","year":"2017","unstructured":"Manchandani P, Zhou J, Babic JT et al (2017) Role of renal drug exposure in polymyxin B-induced nephrotoxicity. Antimicrob Agents Chemother 61:e02391-16. https:\/\/doi.org\/10.1128\/aac.02391-16","journal-title":"Antimicrob Agents Chemother"},{"key":"4566_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics8010024","volume":"8","author":"RL Nation","year":"2019","unstructured":"Nation RL, Rigatto MHP, Falci DR, Zavascki AP (2019) Polymyxin acute kidney injury: dosing and other strategies to reduce toxicity. Antibiotics (Basel) 8:24. https:\/\/doi.org\/10.3390\/antibiotics8010024","journal-title":"Antibiotics (Basel)"},{"key":"4566_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.diagmicrobio.2018.11.008","volume":"94","author":"AF Oliota","year":"2019","unstructured":"Oliota AF, Penteado ST, Tonin FS et al (2019) Nephrotoxicity prevalence in patients treated with polymyxins: a systematic review with meta-analysis of observational studies. Diagn Microbiol Infect Dis 94:41\u201349. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.11.008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4566_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkag044","volume":"81","author":"M \u00d6zdede","year":"2026","unstructured":"\u00d6zdede M, Balli Turhan FN, Gerid\u00f6nmez \u00d6 et al (2026) Comparative nephrotoxicity of polymyxin B versus colistin: evidence from ensemble learning and propensity score matching. J Antimicrob Chemother 81:dkag044. https:\/\/doi.org\/10.1093\/jac\/dkag044","journal-title":"J Antimicrob Chemother"},{"key":"4566_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A et al (2020) The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol 18:e3000410. https:\/\/doi.org\/10.1371\/journal.pbio.3000410","journal-title":"PLoS Biol"},{"key":"4566_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1128\/CMR.00064-16","volume":"30","author":"L Poirel","year":"2017","unstructured":"Poirel L, Jayol A, Nordmann P (2017) Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev 30:557\u2013596. https:\/\/doi.org\/10.1128\/CMR.00064-16","journal-title":"Clin Microbiol Rev"},{"key":"4566_CR17","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1172\/JCI102134","volume":"28","author":"EJ Pulaski","year":"1949","unstructured":"Pulaski EJ, Baker HJ, Rosenberg ML, Connell JF (1949) Laboratory and clinical studies of polymyxin B and E 12. J Clin Invest 28:1028\u20131031. https:\/\/doi.org\/10.1172\/JCI102134","journal-title":"J Clin Invest"},{"key":"4566_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-67171-x","volume":"14","author":"SL Samodelov","year":"2024","unstructured":"Samodelov SL, Gai Z, De Luca F et al (2024) L-carnitine co-administration prevents colistin-induced mitochondrial permeability transition and reduces the risk of acute kidney injury in mice. Sci Rep 14:16444. https:\/\/doi.org\/10.1038\/s41598-024-67171-x","journal-title":"Sci Rep"},{"key":"4566_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4103\/jrpp.jrpp_55_24","volume":"13","author":"AM Shabani","year":"2024","unstructured":"Shabani AM, Alikhani A, Heydari F et al (2024) Evaluation of the effect of N-acetylcysteine in the prevention of colistin nephrotoxicity in critically ill patients: a randomized controlled trial. J Res Pharm Pract 13:85. https:\/\/doi.org\/10.4103\/jrpp.jrpp_55_24","journal-title":"J Res Pharm Pract"},{"key":"4566_CR20","doi-asserted-by":"publisher","first-page":"e135436","DOI":"10.5812\/numonthly-135436","volume":"15","author":"S Shojaei","year":"2023","unstructured":"Shojaei S, Torabi M, Sistanizad M et al (2023) Oral melatonin for Colistin-induced nephrotoxicity reduction in intensive care unit: a randomized placebo controlled clinical trial. Nephro-Urol Mon 15:e135436","journal-title":"Nephro-Urol Mon"},{"key":"4566_CR21","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1007\/s00210-023-02884-w","volume":"397","author":"S Soroudi","year":"2024","unstructured":"Soroudi S, Mousavi G, Jafari F, Elyasi S (2024) Prevention of colistin-induced neurotoxicity: a narrative review of preclinical data. Naunyn-Schmiedebergs Arch Pharmacol 397:3709\u20133727. https:\/\/doi.org\/10.1007\/s00210-023-02884-w","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"4566_CR22","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/nprot.2012.058","volume":"7","author":"M Spinazzi","year":"2012","unstructured":"Spinazzi M, Casarin A, Pertegato V et al (2012) Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells. Nat Protoc 7:1235\u20131246. https:\/\/doi.org\/10.1038\/nprot.2012.058","journal-title":"Nat Protoc"},{"key":"4566_CR23","doi-asserted-by":"crossref","unstructured":"Sulaiman KA, Juhani OA, Alhammad A, et al (2022) The role of adjunctive ascorbic acid in the prevention of colistin-induced nephrotoxicity in critically Ill patients: a retrospective study","DOI":"10.21203\/rs.3.rs-1254017\/v1"},{"key":"4566_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01689","author":"M Vaara","year":"2019","unstructured":"Vaara M (2019) Polymyxins and their potential next generation as therapeutic antibiotics. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2019.01689","journal-title":"Front Microbiol"},{"key":"4566_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2024.141055","volume":"1873","author":"MAE van de Wal","year":"2025","unstructured":"van de Wal MAE, Doornbos C, Bibbe JM et al (2025) Ndufs4 knockout mice with isolated complex I deficiency engage a futile adaptive brain response. Biochimica Et Biophysica Acta (BBA) Prot Proteomics 1873:141055. https:\/\/doi.org\/10.1016\/j.bbapap.2024.141055","journal-title":"Biochimica Et Biophysica Acta (BBA) Prot Proteomics"},{"key":"4566_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.mito.2016.10.005","volume":"31","author":"M Vuda","year":"2016","unstructured":"Vuda M, Kamath A (2016) Drug induced mitochondrial dysfunction: mechanisms and adverse clinical consequences. Mitochondrion 31:63\u201374. https:\/\/doi.org\/10.1016\/j.mito.2016.10.005","journal-title":"Mitochondrion"},{"key":"4566_CR27","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.cmi.2020.12.009","volume":"27","author":"F Wagenlehner","year":"2021","unstructured":"Wagenlehner F, Lucenteforte E, Pea F et al (2021) Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins. Clin Microbiol Infect 27:671\u2013686. https:\/\/doi.org\/10.1016\/j.cmi.2020.12.009","journal-title":"Clin Microbiol Infect"},{"key":"4566_CR28","doi-asserted-by":"publisher","first-page":"11466","DOI":"10.12998\/wjcc.v10.i31.11466","volume":"10","author":"J-L Wang","year":"2022","unstructured":"Wang J-L, Xiang B-X, Song X-L et al (2022) Prevalence of polymyxin-induced nephrotoxicity and its predictors in critically ill adult patients: a meta-analysis. World J Clin Cases 10:11466\u201311485. https:\/\/doi.org\/10.12998\/wjcc.v10.i31.11466","journal-title":"World J Clin Cases"},{"key":"4566_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2023.115440","volume":"233","author":"Y Wang","year":"2023","unstructured":"Wang Y, Yu X, Chen C et al (2023) Development of UPLC-MS\/MS method for the determination of colistin in plasma and kidney and its application in pharmacokinetics. J Pharm Biomed Anal 233:115440. https:\/\/doi.org\/10.1016\/j.jpba.2023.115440","journal-title":"J Pharm Biomed Anal"},{"key":"4566_CR30","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/jac\/dku441","volume":"70","author":"B Yun","year":"2015","unstructured":"Yun B, Azad MAK, Wang J et al (2015) Imaging the distribution of polymyxins in the kidney. J Antimicrob Chemother 70:827\u2013829. https:\/\/doi.org\/10.1093\/jac\/dku441","journal-title":"J Antimicrob Chemother"},{"key":"4566_CR31","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02319-16","volume":"61","author":"AP Zavascki","year":"2017","unstructured":"Zavascki AP, Nation RL (2017) Nephrotoxicity of polymyxins: is there any difference between colistimethate and polymyxin B? Antimicrob Agents Chemother 61:e02319-16. https:\/\/doi.org\/10.1128\/AAC.02319-16","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04566-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-026-04566-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04566-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:04:22Z","timestamp":1790816662000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-026-04566-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":31,"alternative-id":["4566"],"URL":"https:\/\/doi.org\/10.1007\/s00204-026-04566-x","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"15 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}